// App-Quantinova.ai

OP0220 : ASSESSING THE EFFECT OF INCREASED BODY MASS INDEX ON RESPONSE TO TNF INHIBITORS IN ESTABLISHED RHEUMATOID ARTHRITIS: RESULTS FROM THE METEOR DATABASE

Researchers

Presenter

  • M. Dey

Principal Investigators

  • S. S. Zhao

  • R. J. Moots

  • R. B. M. Landew

  • N. Goodson

Medical Centers

  • Institute of Ageing and Chronic Disease, University of Liverpool, Musculoskeletal Biology I, Liverpool, United Kingdom

  • Aintree University Hospital, Liverpool University Hospitals NHS Foundation Trust, Academic Rheumatology, Liverpool, United Kingdom

  • Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands

  • Atrium MC, Rheumatology, Heerlen, Netherlands

Locations

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

  • Obesity

  • Inflammatory Arthritis

Biomarkers

  • Fibrillin-1

  • Tumor necrosis factor

  • Body mass index

Drug/Treatment

  • Adalimumab

  • Infliximab

  • Etanercept

  • CHS-0214

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved